ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于公司及全资孙公司获得高新技术企业证书的公告 | 2019-05-20 | Chinese | |
| 关于参加2019年广东辖区上市公司投资者集体接待日的公告 | 2019-05-17 | Chinese | |
| 关于持股5%以上股东增持股份比例达到1%的公告 | 2019-05-16 | Chinese | |
| 关于实际控制人部分股份质押延期购回及补充质押的公告 | 2019-05-15 | Chinese | |
| 2018年度股东大会的法律意见书 | 2019-05-07 | Chinese | |
| 2018年年度股东大会决议公告 | 2019-05-07 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 36031711 | 关于公司及全资孙公司获得高新技术企业证书的公告 | 2019-05-20 | Chinese | ||
| 36031699 | 关于参加2019年广东辖区上市公司投资者集体接待日的公告 | 2019-05-17 | Chinese | ||
| 36031687 | 关于持股5%以上股东增持股份比例达到1%的公告 | 2019-05-16 | Chinese | ||
| 36031679 | 关于实际控制人部分股份质押延期购回及补充质押的公告 | 2019-05-15 | Chinese | ||
| 36031669 | 2018年度股东大会的法律意见书 | 2019-05-07 | Chinese | ||
| 36031654 | 2018年年度股东大会决议公告 | 2019-05-07 | Chinese | ||
| 36031644 | 关于召开2018年年度股东大会的提示性公告 | 2019-04-30 | Chinese | ||
| 36031633 | 2019年第一季度报告披露的提示性公告 | 2019-04-28 | Chinese | ||
| 36031622 | 2019年第一季度报告全文 | 2019-04-28 | Chinese | ||
| 36031596 | 关于2018年年度股东大会增加临时提案暨股东大会补充通知的公告 | 2019-04-23 | Chinese | ||
| 36031585 | 广发证券股份有限公司关于公司发行股份及支付现金购买资产暨关联交易之2018年度业绩承诺实现情况的核查意见 | 2019-04-22 | Chinese | ||
| 36031570 | 广发证券股份有限公司关于公司发行股份及支付现金购买资产暨关联交易之持续督导意见（2018年度） | 2019-04-22 | Chinese | ||
| 36031556 | 独立董事关于第四届董事会第九次会议相关事项的独立意见 | 2019-04-17 | Chinese | ||
| 36031549 | 关于调增“创新生物药一站式研发生产服务平台”建设投资额的公告 | 2019-04-17 | Chinese | ||
| 36031537 | 第四届监事会第八次会议决议公告 | 2019-04-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.